What’s New in Idiopathic Pulmonary Fibrosis? An Interactive Case Study
January 22, 2021
July 22, 2022
Scroll to the Bottom of this Information to Begin this Course
This activity is provided by Paradigm Medical Communications, LLC.
Supported by an educational grant from Genenetech, Inc.
- Physicians — maximum of 0.25 AMA PRA Category 1 Credit(s)™
All other health care professionals completing this course will be issued a statement of participation.
This activity has been designed to address the educational needs of academic and community-based pulmonologists, radiologists, and pathologists. It may also benefit primary care physicians, nurse practitioners, PAs, pharmacists, nurses, residents, fellows, rheumatologists, and other healthcare professionals involved in the care of patients with idiopathic pulmonary fibrosis(IPF).
COVID-19 imposes a high burden on patients with IPF who are at increased risk for complications and mortality. Using an interactive case study, interstitial lung disease expert Dr Lisa H. Lancaster will navigate the challenges of distinguishing signs and symptoms of COVID-19 from IPF exacerbations, adverse events of IPF medications, and other potential conditions. In addition, Dr Lancaster will share evidence-based strategies for COVID-19 treatment and prevention, and credible, web-based COVID-19 resources that are specific to patients with IPF will be provided.
Upon completion of this activity, participants should be able to:
- Distinguish IPF from mimickers using guideline-recommended, multidisciplinary diagnostic evaluation
- Formulate IPF treatment plans that accord with patient needs and goals
Lisa H. Lancaster, MD
Professor of Medicine
Division of Allergy, Pulmonary, and Critical Care Medicine
Medical Director, Interstitial Lung Disease Program
Vanderbilt University Medical Center
Paradigm Medical Communications, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physician Credit Designation Statement
Paradigm Medical Communications, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PA Continuing Education
PAs may claim a maximum of 0.25 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
Nurse Practitioner Continuing Education
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.
Disclosures of Conflicts of Interest
Lisa H. Lancaster, MD
- Consulting Fees: Bellerophon Therapeutics; Boehringer Ingelheim Pharmaceuticals, Inc; Galapagos NV; Genentech, Inc.
- Speakers Bureau: Boehringer Ingelheim Pharmaceuticals, Inc; Genentech, Inc.
- Grant/Research Support: Bellerophon Therapeutics; Biogen-Idec; Boehringer Ingelheim Pharmaceuticals, Inc; Celgene Corporation; Galapagos NV; Galecto, Inc; Novartis
- Sales Representative: Medtronic
Instructions for Participation and Credit
To receive a CME certificate of participation, you should:
- Follow instructions to register or log in with your professional information and complete the preactivity assessment.
- View the online activity in its entirety.
- Complete and submit the online posttest and evaluation. You must answer 70% of the posttest questions correctly to earn credit. You will have unlimited opportunities to successfully complete the posttest.
For questions regarding CME credit, contact the Paradigm CME Department at (845) 398-5949 or firstname.lastname@example.org.
There is no fee required for participation in this activity.
Course Viewing Requirements
This certified CME activity is designed using HTML5 web components. As you navigate the video using the supplied controls, the slides will sync to the speaker.
Supported Browsers (Desktop/Mobile)
Chrome 45+, Firefox 40+, Edge, Edge Chromium, Safari 8+, Opera 31+
This activity may contain PDF documents. Most current browsers support viewing of PDFs natively, but you may also download a free version of Adobe Acrobat Reader here: http://get.adobe.com/reader
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the FDA.
This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
If included, signed statements of informed consent granting permission for publication have been obtained for all photographs and videos in which an individual can be identified.
As an ACCME-accredited provider, Paradigm Medical Communications, LLC’s activities must include a balanced view of therapeutic options. Use of generic names contributes to this impartiality. The use of trade names should not be viewed as an endorsement of specific products by Paradigm Medical Communications, LLC.
The materials provided for this activity are for informational purposes only, and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Paradigm Medical Communications, LLC. Paradigm Medical Communications, LLC accepts no liability for the content referenced in this activity.
Paradigm Medical Communications, LLC or hosted contracted partner is committed to protecting the privacy of those who participate in the activities located at www.paradigmmc.com (herein referred to as “website”). The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.
Security/safeguarding personal information
This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.
Collection and use of your personal information
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by Paradigm Medical Communications, LLC to continuously improve the learning experience.
Paradigm Medical Communications, LLC does not transfer, sell, or share personal information with outside parties. Paradigm Medical Communications, LLC will not otherwise disclose personal information unless required to in a legal process. Paradigm Medical Communications, LLC staff members review individual test results to the extent necessary to record and track participants’ credits.
If you have any questions or comments, please email us at email@example.com